These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21925455)

  • 1. [Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases].
    Sánchez-Eslava L; Corominas H; Riera M; Fíguls R
    Reumatol Clin; 2011; 7(5):349-50. PubMed ID: 21925455
    [No Abstract]   [Full Text] [Related]  

  • 2. Injection site reactions of adalimumab spreading on the trunk in a psoriatic arthritis patient.
    Kato Y; Kawakami Y; Yamamoto T
    J Dermatol; 2013 Nov; 40(11):931-2. PubMed ID: 24112030
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA OKs two new uses for biologic arthritis drug adalimumab.
    Health News; 2006 Jan; 12(1):2. PubMed ID: 16447312
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aldalimumab in psoriatic arthritis and as the initial therapy in rheumatoid arthritis].
    Krankenpfl J; 2005; 43(7-10):244. PubMed ID: 16515313
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
    Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
    Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
    [No Abstract]   [Full Text] [Related]  

  • 9. An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic.
    Gupta R; Shipa M; Yeoh SA; Buck P; Ehrenstein MR
    Rheumatology (Oxford); 2021 Feb; 60(2):977-979. PubMed ID: 33232489
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
    Immonen K; Kauppi M; Hakala M
    Scand J Rheumatol; 2011 May; 40(3):236-8. PubMed ID: 21231814
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis.
    van Kuijk AW; de Groot M; Stapel SO; Dijkmans BA; Wolbink GJ; Tak PP
    Ann Rheum Dis; 2010 Mar; 69(3):624-5. PubMed ID: 20223840
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
    Genovese MC; Mease PJ; Thomson GT; Kivitz AJ; Perdok RJ; Weinberg MA; Medich J; Sasso EH;
    J Rheumatol; 2007 May; 34(5):1040-50. PubMed ID: 17444593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing inflammatory arthritides: Role of the nurse practitioner and physician assistant.
    Lesko M; Young M; Higham R
    J Am Acad Nurse Pract; 2010 Jul; 22(7):382-92. PubMed ID: 20590962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis.
    Bonafede MM; Gandra SR; Watson C; Princic N; Fox KM
    Adv Ther; 2012 Mar; 29(3):234-48. PubMed ID: 22411424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation.
    Bavbek S; Ataman Ş; Bankova L; Castells M
    Allergol Immunopathol (Madr); 2013; 41(3):204-6. PubMed ID: 23063342
    [No Abstract]   [Full Text] [Related]  

  • 18. Patients' groups welcome NICE decisions on arthritis and multiple sclerosis drugs.
    Cole A
    BMJ; 2007 Sep; 335(7617):416-7. PubMed ID: 17762016
    [No Abstract]   [Full Text] [Related]  

  • 19. Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study.
    Gladman DD; ; Sampalis JS; Illouz O; Guérette B
    J Rheumatol; 2010 Sep; 37(9):1898-906. PubMed ID: 20595284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Br J Dermatol; 2007 Dec; 157(6):1273-4. PubMed ID: 17916219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.